Literature DB >> 6644373

Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.

M Nakajo, B Shapiro, J Glowniak, J C Sisson, W H Beierwaltes.   

Abstract

Heart intensity (HI) in the 24- and 48-hr images of meta-[131I]iodobenzylguanidine (I-131 MIBG), a pheochromocytoma-seeking guanethidine analog, were compared with concentrations of plasma and urinary catecholamines and their metabolites in nonpheochromocytoma and pheochromocytoma patients. HI was inversely related to plasma concentrations and urinary excretion rates of the hormones. Plasma norepinephrine had the highest inverse correlation with HI (r = -0.73 at 24 hr, -0.63 at 48 hr), and urinary metanephrine the lowest (r = -0.23 at 24 hr, -0.28 at 48 hr). A similar relationship was observed in the intensity of salivary-gland visualization, but with less marked variations. HI was much higher in nonpheochromocytoma patients than in pheochromocytoma patients. HI in an I-131 MIBG image provides useful information in the diagnosis of pheochromocytoma, and may provide a tool for the study of the influence of catecholamines on the heart.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644373

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  20 in total

Review 1.  Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.

Authors:  B Shapiro
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

2.  Beyond postural tachycardia syndrome.

Authors:  Hossam I Mustafa; David Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-03       Impact factor: 10.154

3.  Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct.

Authors:  D Fagret; J E Wolf; M Comet
Journal:  Eur J Nucl Med       Date:  1989

4.  123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.

Authors:  I Mitani; S Sumita; N Takahashi; H Ochiai; M Ishii
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

Review 5.  Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

Authors:  A R Wafelman; C A Hoefnagel; R A Maes; J H Beijnen
Journal:  Eur J Nucl Med       Date:  1994-06

6.  Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy.

Authors:  T Kazuta; M Hayashi; T Shimizu; A Iwasaki; S Nakamura; S Hirai
Journal:  Clin Auton Res       Date:  2000-06       Impact factor: 4.435

7.  Sympathetic re-innervation after heart transplantation: dual-isotope neurotransmitter scintigraphy, norepinephrine content and histological examination.

Authors:  C Guertner; B J Krause; H Klepzig; G Herrmann; S Lelbach; E K Vockert; A Hartmann; F D Maul; T W Kranert; E Mutschler
Journal:  Eur J Nucl Med       Date:  1995-05

8.  The usefulness of cardio-vascular visualization in the localization of mediastinal pheochromocytomas with I-131-MIBG.

Authors:  T Başoğlu; P Olivier; T Arsena; P Y Marie; J L Schlienger; G Karcher; A Bertrand
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 9.  Myocardial scintigraphy--25 years after start.

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1988

10.  123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.

Authors:  J Bomanji; J L Hungerford; J E Kingston; D A Levison; K E Britton
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.